» Authors » Lawrence H Schwartz

Lawrence H Schwartz

Explore the profile of Lawrence H Schwartz including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 255
Citations 15639
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Corines M, Ibrahim A, Baheti A, Gibbs P, Sheedy S, Lee S, et al.
Eur J Radiol . 2025 Feb; 184:111986. PMID: 39923594
Background: We explored the use of MRI T2-weighted imaging (T2WI) radiomics to help distinguish acellular mucin from cellular mucin (residual tumor) to inform patient management. Methods: This retrospective, multi-institutional study...
2.
Karunanayake N, Lu L, Yang H, Geng P, Akin O, Furberg H, et al.
Tomography . 2025 Jan; 11(1). PMID: 39852683
Objectives: Accurate kidney and tumor segmentation of computed tomography (CT) scans is vital for diagnosis and treatment, but manual methods are time-consuming and inconsistent, highlighting the value of AI automation....
3.
Arita Y, Kwee T, Akin O, Shigeta K, Paudyal R, Roest C, et al.
Insights Imaging . 2025 Jan; 16(1):7. PMID: 39747744
Bladder cancer is the 10th most common and 13th most deadly cancer worldwide, with urothelial carcinomas being the most common type. Distinguishing between non-muscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder...
4.
Ma J, Yang H, Chou Y, Yoon J, Allison T, Komandur R, et al.
Med Phys . 2024 Nov; 52(2):1005-1018. PMID: 39576046
Background: Tumor assessment through imaging is crucial for diagnosing and treating cancer. Lesions in the liver, a common site for metastatic disease, are particularly challenging to accurately detect and segment....
5.
Zhao B, Dercle L, Yang H, Riely G, Kris M, Schwartz L
Sci Data . 2024 Nov; 11(1):1259. PMID: 39567508
Quantitative imaging biomarkers (QIB) are increasingly used in clinical research to advance precision medicine approaches in oncology. Computed tomography (CT) is a modality of choice for cancer diagnosis, prognosis, and...
6.
Ibrahim A, Guha S, Lu L, Geng P, Wu Q, Chou Y, et al.
PLoS One . 2024 Sep; 19(9):e0310486. PMID: 39269960
Purpose: To assess the reproducibility of radiomic features (RFs) extracted from dynamic contrast-enhanced computed tomography (DCE-CT) scans of patients diagnosed with hepatocellular carcinoma (HCC) with regards to inter-observer variability and...
7.
Ma J, Yoon J, Lu L, Yang H, Guo P, Yang D, et al.
J Appl Clin Med Phys . 2024 Jul; 25(9):e14434. PMID: 39078867
Background: Data collected from hospitals are usually partially annotated by radiologists due to time constraints. Developing and evaluating deep learning models on these data may result in over or under ...
8.
Abou-Alfa G, Geyer S, Nixon A, Innocenti F, Shi Q, Kumthekar P, et al.
Cancer Res Commun . 2024 Feb; 4(3):682-690. PMID: 38363156
Significance: Sorafenib therapy for HCC may impact HCV replication and viral gene expression. In HCV-positive patients accrued to CLAGB 80802 phase III study evaluating the addition of doxorubicin to sorafenib,...
9.
McGale J, Chen D, Trebeschi S, Farwell M, Wu A, Cutler C, et al.
Eur Radiol . 2024 Feb; 34(9):5829-5841. PMID: 38355986
Objective: Immunotherapy has dramatically altered the therapeutic landscape for oncology, but more research is needed to identify patients who are likely to achieve durable clinical benefit and those who may...
10.
Guha S, Ibrahim A, Wu Q, Geng P, Chou Y, Yang H, et al.
PLoS One . 2024 Feb; 19(2):e0294581. PMID: 38306329
Contrast-enhanced computed tomography scans (CECT) are routinely used in the evaluation of different clinical scenarios, including the detection and characterization of hepatocellular carcinoma (HCC). Quantitative medical image analysis has been...